Moreover, the latter 2 studies used alanine transaminase (ALT) and aspartate transaminase (AST) as primary endpoints to assess improvement in fatty liver and did not evaluate intrahepatic fat (IHF), visceral fat area (VFA), or the degree of liver fibrosis. The gene discussed is GPT; the disease is Hepatic fibrosis.